Arineta Installs First SpotLight™ Duo Scanner

The world’s first dedicated cardiothoracic CT scanner was deployed in McKinney, TX

Summation

  • Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, announces the installation of the first SpotLight™ Duo, the highest performance cardiovascular and thoracic CT scanner in the industry in a major health system in Texas.
  • “For patients in need of cardiovascular or cardiothoracic imaging, the SpotLight Duo is the first cardiothoracic CT incorporating all of Arineta's patient centric technologies.
  • This milestone follows Arineta's recent installation of the first SpotLight CT, a sister product to the SpotLight Duo, at Connected Cardiovascular Care Associates in Dallas.

Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, announces the installation of the first SpotLight™ Duo, the highest performance cardiovascular and thoracic CT scanner in the industry in a major health system in Texas. The FDA-cleared SpotLight Duo adds high resolution thoracic clinical capabilities for lung cancer and other pulmonary diseases to its cardiovascular CT technology. This noninvasive system with a reduced physical footprint allows for point-of-care access to diagnostics, therapy planning and monitoring of cardiovascular disease.

The single beat, whole heart scanner is optimized with 140 mm coverage at a rotation speed of 0.24 sec per rotation. Its deep-learning imaging reconstruction (DLIR) technology provides improved image quality by reconstructing cross-sectional images of the subject, allowing for a more complete and accurate CT scan.

“For patients in need of cardiovascular or cardiothoracic imaging, the SpotLight Duo is the first cardiothoracic CT incorporating all of Arineta’s patient centric technologies. With one heartbeat, we can provide both high-temporal as well as iso-temporal resolution images that can be used for comprehensive cardiac and thoracic CT assessment,” said Doug Ryan, CEO of Arineta. “At the same time, we are reducing radiation and contrast for scans while delivering more detailed and accurate images for better informed decision-making by physicians.”

This milestone follows Arineta’s recent installation of the first SpotLight CT, a sister product to the SpotLight Duo, at Connected Cardiovascular Care Associates in Dallas.

More News

Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance

"We are thrilled with the DEA's decision, which underscores the potential of MIRA-55 as a groundbreaking therapeutic candidate," said Erez Aminov, Chairman & CEO of MIRA Pharmaceuticals. "This ruling allows us to focus on MIRA-55's unique cognitive and anxiety benefits. With access to $90B traditional neurological and $30B cannabis markets, MIRA-55 represents a significant value proposition for our company.  We remain committed to advancing it through the development pipeline for treating these diseases from which so many currently suffer."

Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhD

Dr Kambiz Shekdar said: "I gratefully take this opportunity as my solemn commitment to help build up the BioTech sector in Abu Dhabi with the same home-grown can-do-and-have-done record of accomplishment demonstrated by Emirati leadership, its people, and nation, and to do so collegially with the best of the best of the world's human capital across frontier technologies who, like myself, are drawn to the UAE with the thirst to pioneer and build better like only possible in the red-hot entrepreneurial climate of the UAE."

Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startups

"We celebrate the growing base of research and technological advances within the region's health and life sciences sector," said Chandra Briggman, President and CEO of Activation Capital.

By using this website you agree to accept Medical Device News Magazine Privacy Policy